Are you Dr. Chadburn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 76 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
525 E 68th St 715
New York, NY 10065Phone+1 212-746-6631Fax+1 212-746-8173- Is this information wrong?
Summary
- Dr. Amy Chadburn, MD is a board certified pathologist in New York, New York. She is currently licensed to practice medicine in New York, Illinois, and Oregon. She is affiliated with New York-Presbyterian Hospital and is a Professor in Pathology at Northwestern University Medical School.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematopathology, 1989 - 1990- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1984 - 1988
University of Rochester Medical CenterInternship, Transitional Year, 1983 - 1984
Stanford University School of MedicineClass of 1983
Certifications & Licensure
IL State Medical License 2008 - 2026
OR State Medical License 1992 - 2025
NY State Medical License 1984 - 2025- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Top Doctors: New York Metro Area Castle Connolly, 2003-2009
- New York Magazine: Top Doctors Castle Connolly, 2007-2008
Clinical Trials
- Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Start of enrollment: 2013 Mar 05
Publications & Presentations
PubMed
- Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.Jie Li, Christopher R Chin, Hsia-Yuan Ying, Cem Meydan, Matthew R Teater, Min Xia, Pedro Farinha, Katsuyoshi Takata, Chi-Shuen Chu, Yiyue Jiang, Jenna Eagles, Verena P...> ;Nature Communications. 2024 Apr 3
- 1 citationsARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.Darko Barisic, Christopher R Chin, Cem Meydan, Matt Teater, Ioanna Tsialta, Coraline Mlynarczyk, Amy Chadburn, Xuehai Wang, Margot Sarkozy, Min Xia, Sandra E Carson, S...> ;Cancer Cell. 2024 Mar 7
- 1 citationsSMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions.Qing Deng, Priya Lakra, Panhong Gou, Haopeng Yang, Cem Meydan, Matthew Teater, Christopher Chin, Wenchao Zhang, Tommy Dinh, Usama Hussein, Xubin Li, Estela Rojas, Weig...> ;Cancer Cell. 2024 Mar 1
- Join now to see all
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
